|
Market Closed -
Sao Paulo
04:53:47 19/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 57.48 BRL | +0.52% |
|
-0.83% | +5.95% |
| Market Cap | 73.86B 576B 96.76B 88.13B 81.2B 139B 8,960B 146B 988B 393B 4,894B 363B 355B 15,358B | P/E 2026 * |
14.9x | P/E 2027 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 95.76B 746B 125B 114B 105B 180B 11,615B 189B 1,281B 509B 6,344B 471B 461B 19,910B | EV / Sales 2026 * |
2.83x | EV / Sales 2027 * | 2.64x |
| Free-Float |
94.95% | Yield 2026 * |
3.78% | Yield 2027 * | 4.06% |
Last Transcript: GSK plc
| 1 day | +0.52% | ||
| 1 week | -0.83% | ||
| Current month | -4.49% | ||
| 1 month | +14.62% | ||
| 3 months | +6.84% | ||
| 6 months | +12.38% | ||
| Current year | +5.95% |
| 1 week | 56.7 | 58.62 | |
| 1 month | 51.85 | 60.18 | |
| Current year | 46.15 | 63.24 | |
| 1 year | 46.15 | 63.24 | |
| 3 years | 34.7 | 63.24 | |
| 5 years | 30.69 | 63.24 | |
| 10 years | 30.69 | 63.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | 52 | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
James Ford
CMP | Compliance Officer | - | 01/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | 52 | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 67 | 01/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.52% | -0.83% | - | - | 96.76B | ||
| -0.30% | -6.68% | +27.12% | +127.32% | 1,200B | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 651B | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 506B | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 377B | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 330B | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 288B | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 272B | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 236B | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 206B | ||
| Average | +0.35% | -4.76% | +25.01% | +75.64% | 452B | |
| Weighted average by Cap. | +0.31% | -5.19% | +26.02% | +87.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.83B 264B 44.32B 40.36B 37.19B 63.47B 4,104B 66.71B 453B 180B 2,241B 166B 163B 7,035B | 35.28B 275B 46.21B 42.09B 38.78B 66.18B 4,279B 69.55B 472B 188B 2,337B 173B 170B 7,335B |
| Net income | 4.92B 38.33B 6.44B 5.87B 5.41B 9.23B 597B 9.7B 65.8B 26.15B 326B 24.17B 23.66B 1,023B | 6.11B 47.61B 8B 7.29B 6.72B 11.46B 741B 12.05B 81.74B 32.49B 405B 30.03B 29.39B 1,270B |
| Net Debt | 21.89B 171B 28.68B 26.12B 24.07B 41.07B 2,655B 43.16B 293B 116B 1,450B 108B 105B 4,552B | 19.18B 149B 25.12B 22.88B 21.08B 35.98B 2,326B 37.81B 257B 102B 1,271B 94.25B 92.27B 3,987B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/11/26 | R$57.48 | +0.52% | 123 |
| 17/11/26 | R$57.18 | -2.46% | 3 |
| 16/11/26 | R$58.62 | +1.14% | 1 |
| 13/11/26 | R$57.96 | -2.83% | 19 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- GSK Stock
- G1SK34 Stock
Select your edition
All financial news and data tailored to specific country editions

















